课题基金 / 基金详情

Fibronogen-Induced Vasconstriction during Hypertension

Fibronogen-Induced Vasconstriction during Hypertension
高血压期间纤维蛋白原诱导的血管收缩
批准号:
7838826
负责人:
DAVID LOMINADZE
金额:
$26.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2011-12-31

项目摘要

项目成果

DAVID LOMINADZE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hypertension is accompanied by an increased content of plasma fibrinogen (Fg). We reported that binding of Fg to the arterial wall causes vasoconstriction, which is mediated by intercellular adhesion molecule-1 (ICAM-1). In addition, blockade of the endothelin type A receptors attenuated Fg-induced vasoconstriction. In our preliminary studies, endothelial binding of Fg enhanced production of endothelin-1 (ET-1). Furthermore, Fg binding to endothelial cells (ECs) resulted in phosphorylation of extracellular signal regulated kinase (ERK). Activation of ICAM-1 and another Fg endothelial receptor, alpha5beta1 integrin, leads to phosphorylation of ERK and c-Jun-NH2-terminal kinase (JNK). Fg-induced vasoconstriction is increased during hypertension, and regulated production of ET-1 results from exocytosis of Weibel-Palade bodies (WPb). We hypothesize that during hypertension, increased Fg binding to endothelial ICAM-1 (and possibly alpha5beta1) induces enhanced exocytosis of WPbs through ERK (and possibly JNK) signaling and results in increased production of ET-1 leading to enhanced vasoconstriction. Based on our finding that Fg binding to ECs changes EC proteome which may be associated with WPb exocytosis, we will determine if these Fg-induced cellular changes are associated with ET-1 release, and therefore with vasoconstriction. The specific aims of the proposed study are: 1) To evaluate Fg binding to ICAM-1, the resultant production of ET-1, and subsequent vasoconstriction during hypertension; 2) To determine the signaling pathway (ERK- and/or JNK-involved) for Fg-induced ET-1 production and the elevated vasoconstriction during hypertension; and 3) To determine the functional role of EC proteins altered by Fg binding in Fg-induced exocytosis of WPbs during hypertension. Hypertension-induced enhanced Fg binding to endothelial ICAM-1 (and alpha5beta1), the role of ERK (and JNK) signaling and the role of proteins altered by Fg binding to ECs in increased exocytosis of WPbs and production of ET-1, which causes enhanced vasoconstriction, will be determined. Genetic (SHR) and non-genetic (DOCA-salt) rat hypertension models will be studied at early and established stages of hypertension to identify changes associated with the development and maintenance of hypertension. This study will delineate mechanisms of Fg-regulated production of ET-1 and the resultant increased vasoconstriction that exacerbates microcirculatory complications during hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperfibrinogenemia and sphingolipid-mediated cerebrovascular permeability and memory impairment during TBI
  • 批准号:
    10855710
  • 项目类别:
  • 资助金额:
    $75.0万
  • 财政年份:
    2023
  • 负责人:
    DAVID LOMINADZE
  • 依托单位:
Mechanisms of neurodegeneration by a fibrinogen-containing protein complex during traumatic brain injury
  • 批准号:
    10161854
  • 项目类别:
  • 资助金额:
    $37.38万
  • 财政年份:
    2019
  • 负责人:
    DAVID LOMINADZE
  • 依托单位:
Mechanisms of neurodegeneration by a fibrinogen-containing protein complex during traumatic brain injury
  • 批准号:
    10402868
  • 项目类别:
  • 资助金额:
    $37.38万
  • 财政年份:
    2019
  • 负责人:
    DAVID LOMINADZE
  • 依托单位:
Mechanisms of neurodegeneration by a fibrinogen-containing protein complex during traumatic brain injury
  • 批准号:
    10027325
  • 项目类别:
  • 资助金额:
    $33.86万
  • 财政年份:
    2019
  • 负责人:
    DAVID LOMINADZE
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: